The first Biogen trade was made in Q2 2014.
Since then Steven Cohen bought shares seventeen more times and sold shares on 21 occasions. The investor completely sold their stake between Q4 2022 and Q4 2023.
Avg closing price
Price range
Sold -48.1 Thousand shares
Q4 2023
Avg closing price
$245.62
Price range
$222.59
-
$267.94
Sold 92.3% shares (-578 Thousand shares)
Q3 2023
Avg closing price
$267.47
Price range
$253.30
-
$285.89
Sold 10.0% shares (-69.5 Thousand shares)
Q2 2023
Avg closing price
$297.68
Price range
$275.25
-
$318.06
Sold 43.3% shares (-531 Thousand shares)
Q1 2023
Avg closing price
$276.70
Price range
$256.56
-
$292.34
Sold 26.9% shares (-452 Thousand shares)
Q4 2022
Avg closing price
$282.44
Price range
$253.67
-
$306.72
Increased shares by 268.1% (+1.22 Million shares)
Q3 2022
Avg closing price
$212.38
Price range
$194.69
-
$276.61
Increased shares by 375.8% (+360 Thousand shares)
Q2 2022
Avg closing price
$204.43
Price range
$187.54
-
$223.02
Sold 84.3% shares (-516 Thousand shares)
Q1 2022
Avg closing price
$217.46
Price range
$193.77
-
$244.14
Increased shares by 1882.0% (+581 Thousand shares)
Q4 2021
Avg closing price
$257.12
Price range
$223.92
-
$287.77
Sold 87.4% shares (-215 Thousand shares)
Q3 2021
Avg closing price
$327.75
Price range
$282.99
-
$369.05
Increased shares by 112.7% (+130 Thousand shares)
Q2 2021
Avg closing price
$302.94
Price range
$259.00
-
$414.71
Sold 41.9% shares (-83.4 Thousand shares)
Q1 2021
Avg closing price
$269.69
Price range
$242.95
-
$284.63
Increased shares by 71.4% (+82.8 Thousand shares)
Q4 2020